Related Experiment Video
Updated: Jun 25, 2026

Basics of Multivariate Analysis in Neuroimaging Data
Published on: July 24, 2010
Investigating the amyloid-tau-neurodegeneration framework in Alzheimer's disease using semi-supervised multimodal
You Cheng1,2,3, Adrián Medina1,2, Cole Korponay1,2,3
1McLean Hospital Belmont Massachusetts USA.
Introduction:
Alzheimer's disease (AD) heterogeneity complicates diagnosis and prognosis. Uncovering amyloid-tau-neurodegeneration (A-T-N) patterns may improve diagnostic prediction.
Methods:
We applied SuperBigFLICA (SBF), a semi-supervised multimodal fusion method, to gray matter density, cortical thickness (CT), pial surface area, amyloid and tau positron emission tomography maps from 274 Alzheimer's Disease Neuroimaging Initiative 3 participants to derive 50 latent components predictive of cognitive decline. Subject loadings were then used to predict diagnosis (cognitively normal, mild cognitive impairment, dementia) and apolipoprotein E (APOE) ε4 status via least absolute shrinkage and selection operator logistic regression, compared to demographic, single-modality, and naïve fusion comparator models.
Results:
SBF modestly predicted out-of-sample concurrent clinical severity (Clinical Dementia Rating Sum of Boxes; r = 0.21), yet models using SBF-derived loadings were among the strongest comparator models (area under the receiver operating characteristic curve; = 0.80 for diagnosis; 0.83 for APOE ε4). Amyloid alterations in sensory areas best separated dementia, while a tri-modal tau-neurodegeneration pattern related to disease progression. Loadings were validated through cerebrospinal fluid correlations.
Discussion:
SBF improves prediction and reveals interpretable patterns that better classify clinical diagnoses and APOE ε4 than traditional approaches.
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease l: Introduction
Alzheimer Disease ll: Pathophysiology

